Skip to content

Clinical trials

Completed Lung Diseases trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Completed Country / region: Netherlands Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20092
20142
20152
20162
20175
20181
20194
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Bayer2
Erasmus Medical Center2
Novartis Pharmaceuticals2
Radboud University Medical Center2
Consorcio Centro de Investigación Biomédica en Red (CIBER)1
Hoffmann-La Roche1
Integra LifeSciences Corporation1
Leiden University Medical Center1
Maastricht University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases25
Respiratory Tract Diseases7
Asthma4
Cystic Fibrosis4
Lung Diseases, Obstructive4
Neoplasms4
Pulmonary Disease, Chronic Obstructive4
Bronchial Diseases3
Cardiovascular Diseases3
Inflammation3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.